Kevin Xie

CFO at CORXEL

Speaker

Dr. Kevin Xie serves as the Chief Financial Officer at CORXEL, where he oversees the company's capital strategy, financial operations, and investor relations.With over 20 years of experience in healthcare investment and operations, Kevin brings a wealth of expertise and leadership to the organization. Most recently, Kevin served as the Chief Financial Officer of Gracell Biotechnologies, beginning in July 2020. During his tenure, he played a pivotal role in several landmark achievements, including the company's crossover financing in 2020, its Nasdaq IPO in 2021, a subsequent secondary equity PIPE financing in 2023, and Gracell's eventual acquisition by AstraZeneca in 2024. In addition, Kevin also oversaw Gracell's U.S. non-clinical operations. Prior to joining Gracell, Kevin was the President of Healthcare Holdings for Fosun Group and Chief Representative of Fosun NY from 2015 to 2020. In this role, he led Fosun Group's global healthcare investment initiatives. Before Fosun, Kevin spent over a decade in senior management positions at several prominent healthcare investment firms in the United States. He co-founded Locust Walk Capital, served as Healthcare Sector Head at Scopia Capital, and was a Managing Director at Great Point Partners. In addition to his executive roles, Kevin has served on the boards of directors of multiple publicly traded companies. Kevin holds an MBA from The Wharton School at the University of Pennsylvania and a Ph.D. in Chemistry from the City University of New York.